Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognition Disorders × Lamotrigine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 2 Pain 1 Noonan Syndrome 1 Neurotoxicity Syndromes 1 Cognition Disorders 1

Interventions

Transcranial Direct Current Stimulation 1 Spermine Synthase 1 Radiosurgery 1 Palliative Care 1 Modafinil 1 Methods 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Lovastatin 1 Lomustine 1 Lamotrigine 1 Functional Status 1 Exercise 1 Drug Therapy 1 Donepezil 1 DNA Methylation 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03504501 2023-11-30

SynCoRAS

Technical University of Munich

Phase 2 Terminated

Cognition Disorders, Neurofibromatosis 1, Noonan Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡